Oxytocin for use in the treatment of autism and Asperger's disorder.

摘要

Composition comprising oxytocin, oxytocin analog selected from the group consisting of 4-threonine-1-hydroxy-desaminooxitocina, 9-desamido-oxytocin, 7-D-proline-oxytocin and its deamino analog, (2,4- diisoleucina) -oxytocin, desamino-oxytocin analogue 1-deamino-1- monocarba-E12- [Tyr (OMe)] - OT (dCOMOT), carbetocin, Ile-conopresina, atosiban, [Thr4-Gly7] - oxytocin, oxipresina, desamino-6-carba-oxytocin (DC60), d [Lys (8) (5 / 6C-Flu)] VT, d [Thr (4), Lys (8) (5 / 6C-Flu)] VT, [HO (1)] [Lys (8) (5 / 6C-Flu)] VT, [HO (1)] [Thr (4), Lys (8) (5 / 6C-Flu)] VT, d [Orn (8 ) (5 / 6C-Flu)] VT, d [Thr (4), Orn (8) (5 / 6C-Flu)] VT, [HO (1)] [Orn (8) (5 / 6C-Flu) ] VT and [HO (1)] [Thr (4), Orn (8) (5 / 6C-Flu)] VT or combination thereof for use in treating autism or Asperger's disorder.